Results 121 to 130 of about 10,941,841 (309)

Volume 14, Issue 4: Full Issue [PDF]

, 2015

core   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Volume 11, Issue 4: Full Issue [PDF]

, 2014

core   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Corrigendum to "Short-term outcomes of robot-assisted minimally invasive surgery for brainstem hemorrhage: A case-control study" [Heliyon Volume 10, Issue 4, February 2024, Article e25912]. [PDF]

Heliyon
Bao D, Ni S, Chang B, Zhang W, Zhang H, Niu C.   +5 more
europepmc   +1 more source

Editorial for EAIT issue 4, 2023. [PDF]

Educ Inf Technol (Dordr), 2023
Tatnall A.
europepmc   +1 more source

Complete Issue 4, 1989 [PDF]

, 1989

core   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Complete Issue Volume 12 Issue 4

Journal of the Scholarship of Teaching and Learning, 2012
Editor Journal of the Scholarship of Teaching and Learning
doaj   +2 more sources

Erratum to "Yeast cells experience chronological life span extension under prolonged glucose starvation" [Heliyon Volume 11, Issue 4, February 2025, Article e42898]. [PDF]

Heliyon
Mallick S, Shormi AS, Jahan H, Alam MS, Begum RA, Sarker RH, Muid KA.   +6 more
europepmc   +1 more source